BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33061914)

  • 1. Identifying Clinically and Functionally Distinct Groups Among Healthy Controls and First Episode Psychosis Patients by Clustering on EEG Patterns.
    Qu X; Liukasemsarn S; Tu J; Higgins A; Hickey TJ; Hall MH
    Front Psychiatry; 2020; 11():541659. PubMed ID: 33061914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identify Potential Causal Relationships Between Cortical Thickness, Mismatch Negativity, Neurocognition, and Psychosocial Functioning in Drug-Naïve First-Episode Psychosis Patients.
    Li X; Wei W; Wang Q; Deng W; Li M; Ma X; Zeng J; Zhao L; Guo W; Hall MH; Li T
    Schizophr Bull; 2024 Apr; ():. PubMed ID: 38635296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive Impairment of Mismatch Negativity Is Reflective of Underlying Pathophysiological Changes in Patients With First-Episode Psychosis.
    Lho SK; Kim M; Park J; Hwang WJ; Moon SY; Oh S; Kwon JS
    Front Psychiatry; 2020; 11():587. PubMed ID: 32625126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations.
    Hermens DF; Ward PB; Hodge MA; Kaur M; Naismith SL; Hickie IB
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):822-9. PubMed ID: 20302901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal relationships between mismatch negativity, cognitive performance, and real-world functioning in early psychosis.
    Higgins A; Lewandowski KE; Liukasemsarn S; Hall MH
    Schizophr Res; 2021 Feb; 228():385-393. PubMed ID: 33549980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive clusters in first-episode psychosis: Overlap with healthy controls and relationship to concurrent and prospective symptoms and functioning.
    Uren J; Cotton SM; Killackey E; Saling MM; Allott K
    Neuropsychology; 2017 Oct; 31(7):787-797. PubMed ID: 28368139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive subgroups and the relationships with symptoms, psychosocial functioning and quality of life in first-episode non-affective psychosis: a cluster-analysis approach.
    Kam CTK; Fung VSC; Chang WC; Hui CLM; Chan SKW; Lee EHM; Lui SSY; Chen EYH
    Front Psychiatry; 2023; 14():1203655. PubMed ID: 37575584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch negativity is a stronger indicator of functional outcomes than neurocognition or theory of mind in patients with schizophrenia.
    Lee SH; Sung K; Lee KS; Moon E; Kim CG
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():213-9. PubMed ID: 24161665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch Negativity reduction in the left cortical regions in first-episode psychosis and in individuals at ultra high-risk for psychosis.
    Solís-Vivanco R; Mondragón-Maya A; León-Ortiz P; Rodríguez-Agudelo Y; Cadenhead KS; de la Fuente-Sandoval C
    Schizophr Res; 2014 Sep; 158(1-3):58-63. PubMed ID: 25064664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
    Light GA; Braff DL
    Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis.
    Oomen PP; Begemann MJH; Brand BA; de Haan L; Veling W; Koops S; van Os J; Smit F; Bakker PR; van Beveren N; Boonstra N; Gülöksüz S; Kikkert M; Lokkerbol J; Marcelis M; Rosema BS; de Beer F; Gangadin SS; Geraets CNW; van 't Hag E; Haveman Y; van der Heijden I; Voppel AE; Willemse E; van Amelsvoort T; Bak M; Batalla A; Been A; van den Bosch M; van den Brink T; Faber G; Grootens KP; de Jonge M; Knegtering R; Kurkamp J; Mahabir A; Pijnenborg GHM; Staring T; Veen N; Veerman S; Wiersma S; Graveland E; Hoornaar J; Sommer IEC
    Psychol Med; 2023 Apr; 53(6):2317-2327. PubMed ID: 34664546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
    Rydkjær J; Møllegaard Jepsen JR; Pagsberg AK; Fagerlund B; Glenthøj BY; Oranje B
    Psychol Med; 2017 Jan; 47(2):377-388. PubMed ID: 27776572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intact Mismatch Negativity Responses in Clinical High Risk for Psychosis and First-Episode Psychosis: Evidence From Source-Reconstructed Event-Related Fields and Time-Frequency Data.
    Dheerendra P; Grent-'t-Jong T; Gajwani R; Gross J; Gumley AI; Krishnadas R; Lawrie SM; Schwannauer M; Schultze-Lutter F; Uhlhaas PJ
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Jan; 9(1):121-131. PubMed ID: 37778724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forecasting prognostic trajectories with mismatch negativity in early psychosis.
    Kim M; Kim T; Hwang WJ; Lho SK; Moon SY; Lee TY; Kwon JS
    Psychol Med; 2023 Mar; 53(4):1489-1499. PubMed ID: 36315242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophrenia.
    Kaser M; Soltesz F; Lawrence P; Miller S; Dodds C; Croft R; Dudas RB; Zaman R; Fernandez-Egea E; Müller U; Dean A; Bullmore ET; Nathan PJ
    PLoS One; 2013; 8(12):e83255. PubMed ID: 24358266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review.
    Nagai T; Tada M; Kirihara K; Araki T; Jinde S; Kasai K
    Front Psychiatry; 2013 Sep; 4():115. PubMed ID: 24069006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration Mismatch Negativity Predicts Remission in First-Episode Schizophrenia Patients.
    Nakajima S; Higuchi Y; Tateno T; Sasabayashi D; Mizukami Y; Nishiyama S; Takahashi T; Suzuki M
    Front Psychiatry; 2021; 12():777378. PubMed ID: 34899430
    [No Abstract]   [Full Text] [Related]  

  • 20. Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.
    Koshiyama D; Kirihara K; Tada M; Nagai T; Koike S; Suga M; Araki T; Kasai K
    Schizophr Res; 2017 Dec; 190():32-38. PubMed ID: 28314681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.